Ausiello Dennis A
Known title: DirectorCIK: 0001381994
Associated companies
Transaction History
| ALNY | ▲ Buy | Grant | 671 | $0 | 5/20/2026 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 5,228 | $791K | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 1,985 | $855K | 8/14/2025 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 9,000 | $648K | 8/14/2025 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 5,153 | $661K | 8/14/2025 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 4,581 | $682K | 8/14/2025 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 4,032 | $693K | 8/14/2025 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 3,454 | $656K | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 1,938 | $839K | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 2,098 | $912K | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 7,675 | $3.3M | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 5,358 | $2.3M | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 1,922 | $841K | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 2,086 | $914K | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 5,302 | $2.3M | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 1,238 | $545K | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 1,205 | $532K | 8/14/2025 | View on chart |
| ALNY | ▼ Sell | Open Market | 641 | $284K | 8/14/2025 | View on chart |
| ALNY | ▲ Buy | Grant | 775 | $0 | 5/8/2025 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 11,250 | $1.5M | 8/6/2024 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 9,000 | $947K | 8/6/2024 | View on chart |
| ALNY | ▼ Sell | Open Market | 1,627 | $422K | 8/6/2024 | View on chart |
| ALNY | ▼ Sell | Open Market | 3,742 | $974K | 8/6/2024 | View on chart |
| ALNY | ▼ Sell | Open Market | 6,212 | $1.6M | 8/6/2024 | View on chart |
| ALNY | ▼ Sell | Open Market | 4,367 | $1.1M | 8/6/2024 | View on chart |
| ALNY | ▼ Sell | Open Market | 3,408 | $899K | 8/6/2024 | View on chart |
| ALNY | ▼ Sell | Open Market | 632 | $167K | 8/6/2024 | View on chart |
| ALNY | ▼ Sell | Open Market | 262 | $70K | 8/6/2024 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 136 | $0 | 2/23/2023 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 11,250 | $790K | 11/21/2022 | View on chart |
| ALNY | ▼ Sell | Open Market | 22,500 | $5.0M | 11/21/2022 | View on chart |
| ALNY | ▲ Buy | Option Exercise | 11,250 | $810K | 11/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Alnylam Q3 Earnings Call Set; Analysts Adjust Targets
Alnylam Pharmaceuticals is preparing to discuss its third-quarter 2026 financial results in an upcoming webcast. Ahead of this event, Citigroup and Wells Fargo maintained their ratings but lowered their price targets to $320 and $253, respectively. These adjustments occur while the stock trades near its 52-week low, reflecting a cautious market stance despite ongoing RNAi commercial momentum.
Alnylam Q3 Earnings Call Set; Analysts Adjust Targets. Alnylam Pharmaceuticals is preparing to discuss its third-quarter 2026 financial results in an upcoming webcast. Ahead of this event, Citigroup and Wells Fargo maintained their ratings but lowered their price targets to $320 and $253, respectively. These adjustments occur while the stock trades near its 52-week low, reflecting a cautious market stance despite ongoing RNAi commercial momentum.